Rituximab: A new therapeutic alternative in rheumatoid arthritis
Authors:
- Jean SibiliaJSJean Sibilia
- Jacques-Eric GottenbergJGJacques-Eric Gottenberg
- Xavier MarietteXMXavier Mariette
- 1 October 2008
- journal article
- review article
- Published by Elsevier in Joint Bone Spine
- Vol. 75 (5) , 526-532
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Biologics in the treatment of primary inflammatory myositisJoint Bone Spine, 2007
- Rituximab in rheumatic diseasesJoint Bone Spine, 2007
- B Cells in Health and DiseaseMayo Clinic Proceedings, 2006
- B lymphocytes on the front line of autoimmunityAutoimmunity Reviews, 2006
- Rituximab maintenance therapy in indolent NHL: a clinical reviewLeukemia Research, 2006
- RituximabDrugs, 2006
- B cell non-Hodgkin's lymphoma: rituximab safety experienceArthritis Research & Therapy, 2005
- Unique Toxicities and Resistance Mechanisms Associated with Monoclonal Antibody TherapyHematology-American Society Hematology Education Program, 2005
- The Biology of CD20 and Its Potential as a Target for mAb Therapy2004
- Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20Blood, 1994